We hypothesized that retention of CLL cells in the lymph nodes results at least in part from an inability to exit due to repression of S1PR1 expression by chronic BCR signaling, and that the CLL cell–mobilizing effects of BCR signaling inhibitors result from the reversal of such repression. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.